AMCR
Amcor plc
AMCR has the edge over NIO overall, supported by stronger valuation and lower modeled downside.
NIO
NIO Inc.
NIO offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
AMCR Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Weak |
AMCR's revenue and profitability are currently healthy, and its cash flow is stable, but its balance sheet is weak.
NIO Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Stable | |
| Unavailable |
NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.
AMCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 17x | $38.71 | -12% |
| Current | 19x | $43.80 | — |
| Fair | 21x | $49.43 | +13% |
| Expensive | 28x | $64.25 | +47% |
Historical ranges are pointers, not guarantees.
AMCR's PE is in its cheap range at 19x.
NIO PE Valuation
NIO has no meaningful PE right now: it lost money over the past year.
AMCR Forward outlook
There aren't enough analyst estimates for AMCR to show an outlook.
NIO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect NIO's losses to shrink, with revenue growing.
AMCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $2.33 | +36% |
| Q2 2026 | $2.38 | +31% |
| Q1 2026 | $1.45 | -48% |
| Q4 2025 | $1.53 | -45% |
| Q3 2025 | $1.71 | -36% |
| Q2 2025 | $1.81 | -28% |
| Q1 2025 | $2.80 | +24% |
| Q4 2024 | $2.76 | +25% |
AMCR has the edge over NIO on earnings quality, reporting a profit while its opponent remains loss making.
NIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.29 | +$1.45 |
| Q1 2026 | -$0.60 | +$1.16 |
| Q4 2025 | -$1.06 | +$0.60 |
| Q3 2025 | -$1.59 | +$0.02 |
| Q2 2025 | -$1.74 | -$0.10 |
| Q1 2025 | -$1.76 | +$0.06 |
| Q4 2024 | -$1.66 | +$0.21 |
| Q3 2024 | -$1.61 | +$0.32 |
NIO is still losing money, but far less than before: $0.29 per share over the past year, against $1.93 at its worst in late 2023.
AMCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $6.1B | +6.7% |
| Q2 2026 | $6.4B | +26% |
| Q1 2026 | $5.9B | +77% |
| Q4 2025 | $5.4B | +68% |
| Q3 2025 | $5.7B | +71% |
| Q2 2025 | $5.1B | +44% |
| Q1 2025 | $3.3B | -2.3% |
| Q4 2024 | $3.2B | -0.3% |
AMCR's revenue has grown year over year for six quarters in a row: $6.1B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.4% | -0.6 points |
| Q2 2026 | 10% | +8.4 points |
| Q1 2026 | 7.8% | -1.6 points |
| Q4 2025 | 6.1% | -3.1 points |
| Q3 2025 | 8% | -1.3 points |
| Q2 2025 | 1.7% | -9.5 points |
| Q1 2025 | 9.4% | +0.4 points |
| Q4 2024 | 9.2% | +1.7 points |
AMCR has the edge over NIO on profitability, with a higher operating margin.
NIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.8B | +69% |
| Q1 2026 | $3.8B | +112% |
| Q4 2025 | $5.2B | +76% |
| Q3 2025 | $3.3B | +17% |
| Q2 2025 | $2.9B | +9% |
| Q1 2025 | $1.8B | +21% |
| Q4 2024 | $3B | +15% |
| Q3 2024 | $2.8B | -2.1% |
NIO's revenue has grown year over year for seven quarters in a row: $4.8B last quarter, up 69% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.1% | +24 points |
| Q1 2026 | -1.2% | +52 points |
| Q4 2025 | 2.3% | +33 points |
| Q3 2025 | -16% | +12 points |
| Q2 2025 | -26% | +4 points |
| Q1 2025 | -53% | +1.1 points |
| Q4 2024 | -31% | +8.1 points |
| Q3 2024 | -28% | -2.6 points |
NIO's operating margin was −2.1% last quarter, up 24 points from the same quarter a year ago.
AMCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$828M | -$457M |
| Q2 2026 | $1.4B | +52% |
| Q1 2026 | -$42M | -$42M |
| Q4 2025 | $282M | -15% |
| Q3 2025 | -$371M | +$43M |
| Q2 2025 | $894M | +11% |
| Q1 2025 | $0 | -100% |
| Q4 2024 | $330M | +36% |
AMCR usually generates cash, though not every quarter: the latest was −$828M, but it generated $772M over the past year.
NIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | +$2.1B |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | +$391.3M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | -$2.1B | +$73.9M |
| Q1 2025 | $0 | $0 |
| Q4 2024 | -$391.3M | -386% |
| Q2 2024 | -$2.2B | +$337.9M |
NIO's free cash flow was $0 over the past year, against −$2.5B the year before.
AMCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.2x | High |
| Q2 2026 | 3.9x | Elevated |
| Q1 2026 | 5.2x | High |
| Q4 2025 | 5.9x | High |
| Q3 2025 | 6.7x | High |
| Q2 2025 | 7.7x | High |
| Q1 2025 | 3.6x | Elevated |
| Q4 2024 | 3.5x | Elevated |
AMCR's net debt is about 4.2 years of its operating earnings (EBITDA), down from 6.7 years a year ago.
NIO Net Leverage
NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
AMCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.1 | Neutral |
| Stochastic | 53.5 | Neutral |
AMCR's weekly RSI is 50 (neutral) and its Stochastic is 54 (neutral).
NIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 6.9 | Oversold |
NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).
AMCR PE vs Consumer Cyclical Sector
| Metric | AMCR | Sector median | Relative |
|---|---|---|---|
| PE | 19x | 18x | 4.1% above |
| PE % | 27 | 47 | 20 pts below |
AMCR is trading at 19x earnings, in line with the Consumer Cyclical sector's median of 18x.
NIO PE vs Consumer Cyclical Sector
NIO has no meaningful PE right now: it lost money over the past year.
AMCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.0 | 0.5% below |
| 20 week MA | $44.6 | 1.8% below |
| 50 week MA | $42.9 | 2% above |
| 100 week MA | $44.3 | 1.2% below |
| 200 week MA | $47.4 | 7.5% below |
AMCR has the edge over NIO on trend strength, trading above more of its moving averages.
NIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.36 | 9.2% below |
| 20 week MA | $4.01 | 24% below |
| 50 week MA | $4.81 | 37% below |
| 100 week MA | $4.85 | 37% below |
| 200 week MA | $6.03 | 49% below |
NIO is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.
AMCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.8 | $58.2 | +6.3% |
| 2021 | $58.2 | $58.3 | +0.2% |
| 2022 | $58.3 | $60.3 | +3.4% |
| 2023 | $60.3 | $48.2 | -20% |
| 2024 | $48.2 | $47.2 | -2.1% |
| 2025 | $47.2 | $41.6 | -12% |
| 2026 YTD | $41.6 | $43.8 | +5.3% |
AMCR has the edge over NIO on returns for 2026, with the stronger performance.
NIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.42 | $45.8 | +1791% |
| 2021 | $45.8 | $30.5 | -33% |
| 2022 | $30.5 | $11.0 | -64% |
| 2023 | $11.0 | $9.07 | -17% |
| 2024 | $9.07 | $4.48 | -51% |
| 2025 | $4.48 | $5.10 | +14% |
| 2026 YTD | $5.10 | $3.05 | -40% |
NIO's yearly returns have swung widely, from +1791% in 2020 to −64% in 2022. It's down 40% so far in 2026.